The nation of Zimbabwe has turned down a substantial US healthcare agreement valued at 367 million US dollars (272 million pounds) over five years over the United States' insistence on confidential information.
The decision became public following a government memo from December was leaked, indicating that President Emmerson Mnangagwa felt the arrangement was "skewed".
A government spokesman has since clarified that the US was requesting biological samples for research and profit but was not willing to share the benefits from any future treatments.
"We will now turn to the challenging and unfortunate process of ending our health assistance in Zimbabwe," remarked American envoy to Zimbabwe Pamela Tremont in a statement.
The US Embassy noted the US had provided more than $1.9bn as health assistance to Zimbabwe during the past two decades.
A medical body in Zimbabwe has called for more dialogue to secure a agreement acceptable to both sides so the country's critical HIV programme can proceed.
Broader Background
Zimbabwe's decision comes after a similar situation in Kenya, where a high court halted a similar deal with the US following concerns were raised about the safety of citizens' health data.
After returning to office last year, US President Donald Trump has slashed overseas assistance and closed the US Agency for International Development (USAID).
USAID had managed assistance for the American government, but Trump stated its spending was "inefficient" and his government was seeking direct bilateral agreements to enhance transparency and accountability.
As per reports, Sixteen nations in Africa have to date signed similar health pacts, constituting over $18.3bn in new funding.
Details of the Rejected Agreement
The money for Zimbabwe would have funded "combating HIV/Aids, TB, malaria, healthcare for mothers and children, and preparing for epidemics".
"We are confident this collaboration might have yielded significant benefits for Zimbabwean communities, especially the 1.2 million presently receiving antiretroviral therapy via US-supported programmes," the Ambassador added.
However, government spokesperson Nick Mangwana maintained the arrangement was "unfair".
"Zimbabwe was being asked to provide its genetic material and health information over an extended period, with no equivalent assurance of access to any scientific breakthroughs – like new medicines or tests – that could be developed from that shared data," he stated.
"In essence, our nation would supply the basic resources for scientific discovery with no certainty that the final treatments would be available to our population if a future pandemic emerge."
National Interest and Global Health
He also said that the US's withdrawal from the World Health Organization (WHO) and its pursuit of bilateral health agreements were upending frameworks previously set up via the international organization.
The spokesperson gave as an example its Pathogen Access and Benefit Sharing framework created to manage potential pandemics.
"This framework is intended to guarantee that when a nation contributes its samples, the resulting advantages – including vaccines and treatments – are distributed fairly, not commercialised exclusively by those with the capability to create them."
The government's concerns regarding the US deal "must not be interpreted as anti-American sentiment," he added.
"We encourage continued discussions with our American counterparts on how subsequent collaboration might be arranged in a way that honours the independence and interests of each country."
Health Experts Reaction
Medical experts expressed it recognised the government's concerns, but recommended that negotiations should continue given that much of the nation's HIV programmes were funded by international support.
"In cases where technical issues exist, including those involving data governance or implementation frameworks, these can frequently be addressed through technical clarification and mutually agreed protections," the group commented.
The halted deal emphasises the complex tensions between accepting vital foreign assistance and safeguarding national sovereignty in an ever more interconnected world.